Global Tuberculosis Testing Strategic Business Report 2024: Market to Reach $3.1 Billion by 2030 – Present Limitations and Future Directions

DUBLIN, Jan. 15, 2024 /PRNewswire/ — The “Tuberculosis Testing – Global Strategic Business Report” report has been added to  ResearchAndMarkets.com’s offering.

Global Tuberculosis Testing Market to Reach $3.1 Billion by 2030

The global market for Tuberculosis Testing estimated at US$2 Billion in the year 2022, is projected to reach a revised size of US$3.1 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2022-2030. Culture-Based Tests, one of the segments analyzed in the report, is projected to record 5.9% CAGR and reach US$756.5 Million by the end of the analysis period. Growth in the Chest X-Ray segment is estimated at 4.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $125.8 Million, While China is Forecast to Grow at 6.1% CAGR

The Tuberculosis Testing market in the U.S. is estimated at US$125.8 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$397 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 3.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

What`s New?

Special discussions on the global economic climate and market sentimentCoverage on global competitiveness and key competitor percentage market sharesMarket presence analysis across multiple geographies – Strong/Active/Niche/TrivialOnline interactive peer-to-peer collaborative bespoke updatesAccess to digital archives and trademarked research platformComplimentary updates for one yearAccess to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

MARKET OVERVIEW

Tuberculosis, a Disease that Wont Quit: Global Prevalence of Tuberculosis (In 000s) by Geographic Region for the Year 2022Tuberculosis Prevalence Rate Remains High Among Asian Americans: % TB Prevalence in the United States by Race/Ethnicity as of the Year 2022Tuberculosis Prevalence Rate In (%) in the United States by Origin of Birth as of the Year 2022The US Makes Steady Progress Towards TB Elimination: Number of TB Cases for Years 1985, 1995, 2005, 2015, 2020 and 2022Low Funding Remains Palpable ChallengeFunding for Tuberculosis is Vital for Reaching the Elimination Threshold Which is Defined as 1 Case Per 1,000,000 People: U.S. Funding for Tuberculosis (In US$ Million) for Years 2001, 2005, 2009, 2013, 2017, 2021, 2023Surge in Tuberculosis Deaths amid COVID-19: A Wake-Up Call to Drive R&D FundingEfforts to Integrate Testing for TB & COVID-19World Market TrajectoriesTuberculosis Testing – Global Key Competitors Percentage Market Share in 2022 (E)Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)Global Market Overview and OutlookGlobal Tuberculosis Testing Market Exuding High Degree of Vim & VigorNorth America Claims Commanding Revenue ShareCulture-based Tests & Hospitals: Primary Contributors to Tuberculosis Testing MarketSalient Factors Influencing Dynamism of Global Tuberculosis Testing MarketIntense Competition Drive Players to Bet on InnovationsMolecular Diagnosis Innovations Soaking Up Limelight in the Tuberculosis Testing ArenaW.H.O Aims to Improve Access to Rapid Molecular Tests for Diagnosis of TB & Drug-Resistant TBWHO-Endorsed Molecular Platforms & TestsRecent Market Activity

MARKET TRENDS & DRIVERS

Global Tuberculosis Efforts to Drive the Market for Tuberculosis TestingBracing Technological Innovations, Tuberculosis Testing Moves in New DirectionTuberculosis Screening: The Dawn of Artificial Intelligence TechnologyNanodiagnostics Set to Witness Growth in TB TestingA Nanobiosensor for Rapid Detection of Mycobacterium TuberculosisCRISPR-based Biosensing to See Significant Growth in Pediatric TuberculosisPresent Limitations and Future Directions

FOCUS ON SELECT PLAYERS (Total 55 Featured)

Abbott Laboratories, Inc.Becton, Dickinson and CompanyBio-Rad Laboratories, Inc.bioMerieux SADanaher CorporationCepheidDaan Gene Co., Ltd.Akonni Biosystems, Inc.Anatolia Tani ve Biyoteknoloji Urunleri Ar-Ge San. ve Tic. ASCreative DiagnosticsAccuquika” Test KitsAID GmbHAB ANALITICA s.r.l.Bioneovan Co., Ltd.CTK Biotech, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/qkpy82

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-tuberculosis-testing-strategic-business-report-2024-market-to-reach-3-1-billion-by-2030—present-limitations-and-future-directions-302034877.html

SOURCE Research and Markets